PTAB challenges

The search results provide general information about PTAB proceedings and recent policy changes but do not give specific details about IPR2026-00222 itself, such as the claims challenged, prior art, or specific judges. The USPTO Open Data Portal link for "PTAB Decisions" seems to be a general search interface rather than a direct link to specific case documents. Similarly, Unified Patents lists IPRs but doesn't provide the detailed petition grounds or judge panel without navigating their specific portal.

Given that the IPR was filed on 2026-01-20 and the current date is 2026-05-28, it is highly unlikely an Institution Decision has been issued yet, as the PTAB has up to six months to decide (which would be around July 20, 2026). Recent policy changes indicate that institution decisions are now made by the USPTO Director, John Squires, since October 2025, rather than by a panel of APJs. Also, recent memos emphasize discretionary denial factors, including U.S. manufacturing activity.

Since the search didn't yield the detailed information like petition grounds or specific judge panels for this pending IPR, I will state that this information is not yet publicly available or would require accessing the specific case files within the USPTO's E2E system. I will clearly state that no institution decision has been made yet.

Revised Plan:

1. State the total count and status of the proceeding.
2. For IPR2026-00222:
   • Confirm Type, Filed, Status.
   • State that the judge panel is not publicly available yet, as institution is pending.
   • State that petition grounds are not publicly detailed in search results and would require accessing the full petition document from the PTAB E2E system. However, I can infer typical grounds.
   • State that the institution decision is pending and note the approximate deadline. Mention the Director's role in institution.
   • FWD, settlement, appeal: Not applicable as the case is pending.
   • Defensive value: Comment on the pending status and what it means for a defendant.
3. Strategic summary: Based on only one pending IPR, the patent remains largely untested.
4. Recommended next steps: Advise monitoring the institution decision and its deadline.

I have enough information to proceed without further searches, given the limitations of publicly available summarized data for a pending IPR at this early stage.## Proceedings overview

There is one AIA trial proceeding on file for US patent 12233871, which is currently active. The proceeding is an Inter Partes Review (IPR) and is in a pending status, meaning no final decision has been reached regarding the patentability of the challenged claims. This indicates that the patent is currently undergoing a validity challenge, and its claims remain untested by the PTAB.

IPR2026-00222 — Tesla, Inc. v. Bulletproof Property Management LLC

• Type: Inter Partes Review
• Filed: 2026-01-20
• Status: Pending. This IPR proceeding is currently active, and an institution decision has not yet been issued by the Patent Trial and Appeal Board.
• Judge panel: The specific Administrative Patent Judges (APJs) assigned to the merits panel are not publicly available at this early stage of the proceeding, as institution is pending. Since October 2025, institution decisions are made by the USPTO Director, John Squires, rather than a panel of APJs.
• Petition grounds: The detailed petition grounds (e.g., specific claims challenged, prior art references, and statutory bases under § 102 for anticipation or § 103 for obviousness) are not readily available in public search results without accessing the full petition document from the USPTO PTAB E2E system. Generally, IPRs challenge patent claims based on anticipation or obviousness in view of patents or printed publications.
• Institution decision: Pending. The Patent Trial and Appeal Board has a statutory deadline of six months from the petition filing date to issue a decision on whether to institute an IPR. For IPR2026-00222, filed on 2026-01-20, the institution decision is expected around July 20, 2026. The decision will be made by the USPTO Director.
• Final Written Decision (if issued): Not applicable; the proceeding is pending.
• Settlement / termination: Not applicable; the proceeding is pending.
• Appeal: Not applicable; the proceeding is pending.
• Defensive value: As this IPR is pending, the patent's claims are currently under challenge, creating uncertainty regarding their validity. A defendant facing assertion of this patent should closely monitor the institution decision for IPR2026-00222, as institution could signal a potential weakening of the patent's enforceability.

Strategic summary

Currently, all claims of US patent 12233871 remain untested by a final PTAB decision, as the sole Inter Partes Review, IPR2026-00222, is still pending institution. No claims have been canceled or sustained through an AIA trial. The patent is therefore fully intact, but its future validity is uncertain pending the outcome of this IPR.

Regarding the estoppel landscape, since IPR2026-00222 is pending, no estoppel has yet attached under § 315(e)(2). If the IPR is instituted, Tesla, Inc. (and any privies) would be estopped from asserting invalidity grounds in district court that they raised or reasonably could have raised in the IPR. For other potential defendants, all prior-art grounds remain available to challenge the patent's validity until and unless claims are found patentable in a final written decision. There is no clear pattern of repeated IPR filings by the same petitioner, nor is there information on aggressive PTAB appeals by the patent owner or involvement of a defensive aggregator like Unified Patents, as this is the only proceeding on record.

Recommended next steps

If you are a defendant facing assertion of US patent 12233871, your primary focus should be on IPR2026-00222.

• Monitor the PTAB's institution decision for IPR2026-00222, which is expected around 2026-07-20. This decision will indicate whether the PTAB finds a reasonable likelihood that at least one challenged claim is unpatentable, allowing the trial to proceed.
• If the IPR is instituted, closely track the trial stage milestones, including the scheduling order for discovery, expert reports, oral hearing (if scheduled), and the one-year statutory deadline for the Final Written Decision from the institution date.
• The USPTO Director's recent policy on considering U.S. manufacturing activity in institution decisions could be a factor in the outcome of IPR2026-00222.
• The absence of prior PTAB activity means the patent has not yet been subjected to rigorous review under the AIA trial procedures, and its claims are entirely untested in this forum.